Hostname: page-component-848d4c4894-p2v8j Total loading time: 0.001 Render date: 2024-05-31T16:20:27.925Z Has data issue: false hasContentIssue false
  • English
  • Français

Defining the Scope of Public Engagement: Examining the “Right Not to Know” in Public Health Genomics

Published online by Cambridge University Press:  01 January 2021

Clarissa Allen ,
Karine Sénécal  and
Denise Avard
Get access Rights & Permissions [Opens in a new window]

Extract

While the realm of bioethics has traditionally focused on the rights of the individual and held autonomy as a defining principle, public health ethics has at its core a commitment to the promotion of the common good. While these two domains may at times conflict, concepts arising in one may also be informative for concepts arising in the other. One example of this is the concept of a “right not to know.” Recent debate suggests that just as there is a “right to know” information about one's genetic status, there is a parallel “right not to know” when it comes to genetic information that if communicated, could be detrimental to an individual's social or psychological well-being. As new genetic technologies continue to change the nature of genetic testing and screening, it is crucial that normative frameworks to guide and assess genetic public health initiatives be developed. In this context, the question of whether a “right not to know” may also be said to exist for populations on a public health level merits attention.

Type
Symposium
Information
Journal of Law, Medicine & Ethics , Volume 42 , Issue 1 , Spring 2014 , pp. 11 - 18
Copyright
Copyright © American Society of Law, Medicine and Ethics 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bayer, R. Fairchild, A. L., “The Genesis of Public Health Ethics”, Bioethics 18, no. 6 (2004): 473–492.CrossRefGoogle ScholarPubMed
Andorno, R., “The Right Not to Know: An Autonomy Based Approach”, Journal of Law, Medicine & Ethics 30, no. 5 (2004): 435–440.CrossRefGoogle ScholarPubMed
Avard, D. et al.., “Public Involvement in Health Genomics: The Reality Behind the Policies”, International Journal of Consumer Studies 34, no. 5 (2010): 508–524; Rothwell, E. Anderson, R., and Botkin, J., Policy Issues and Stakeholder Concerns Regarding the Storage and Use of Residual Newborn Dried Blood Samples for Research, Policy, Politics, & Nursing Practice 11, no. 1 (2010): 5–12; Corporate Consultation Secretariat, Health Policy and Communications Branch, The Health Canada Policy Toolkit for Public Involvement in Decision Making, Cat. No.: H39-549/2000E (2000).CrossRefGoogle Scholar
Massée, R., Ethique et Santée Publique (Saint Nicolas, Quéebec: Les Presses de l'Universitée Laval, 2003): at 213.Google Scholar
Carlsten, C. Burke, W., “Potential for Genetics to Promote Public Health: Genetics Research on Smoking Suggests Caution About Expectations”, JAMA 296, no. 20 (2006): 2480–2482.CrossRefGoogle ScholarPubMed
Boyce, A. Borry, P., “Parental Authority, Future Autonomy, and Assessing Risks of Predictive Genetic Testing in Minors”, Bioethical Inquiry 6, no. 3 (2009): 379–385.CrossRefGoogle Scholar
Joly, Y. Feze, I. N., and Simard, J., “Genetic Discrimination and Life Insurance: A Systematic Review of the Evidence”, BMC Medicine 11, no. 25 (2013): Available at <http://www.biomedcentral.com/1741-7015/11/25> (last visited January 14, 2014).CrossRefGoogle Scholar
See Massëe, A, supra note 4.Google Scholar
Howard, H. C. et al., “The Ethical Introduction of Genome Based Information and Technologies into Public Health”, Public Health Genomics 16, no. 3 (2013): 100–109.CrossRefGoogle ScholarPubMed
See Avard, et al., supra note 3.Google Scholar
Brand, A. Brand, H., and Shulte, T. in Den, Baüumen, “The Impact of Genetics and Genomics on Public Health”, European Journal of Human Genetics 16, no. 5 (2008): 5–13.CrossRefGoogle ScholarPubMed
Cleeren, E. et al., “Public Health in the Genomic Era: Will Public Health Genomics Contribute to Major Changes in the Prevention of Common Diseases?”, Archives of Public Health 69, no. 8 (2011): 1–12.CrossRefGoogle ScholarPubMed
Id.Google Scholar
See Brand, supra note 11.Google Scholar
Presidential Commission for the Study of Bioethical Issues, Privacy and Progress in Whole Genome Sequencing (October 2012).Google Scholar
Swartling, U. et al., “Concern, Pressure and a Lack of Knowledge Affect Choice of Not Wanting to Know”, European Journal of Human Genetics 15, no. 5 (2007): 556–562.CrossRefGoogle Scholar
See Cleeren, et al., supra note 12.Google Scholar
Bombard, Y. Miller, F. A., “Reply to Ross’ Commentary: Reproductive Benefit through Newborn Screening: Preferences, Policy, and Ethics”, European Journal of Human Genetics 20, no. 5 (2012): 486–487.CrossRefGoogle Scholar
Khoury, M. J. et al., “The Continuum of Translation Research in Genomic Medicine: How Can We Accelerate the Appropriate Integration of Human Genome Discoveries into Health Care and Disease Prevention?”, Genetic Medicine 9, no. 10 (2007): 665–674.CrossRefGoogle ScholarPubMed
See Brand, , supra note 11.Google Scholar
Burke, W. et al., “The Path from Genome-Based Research to Population Health: Development of an International Public Health Genomics Network”, Genetics in Medicine 8, no. 7 (2006): 451–458.CrossRefGoogle ScholarPubMed
See Brand, et al., supra note 11.Google Scholar
Id.Google Scholar
See Avard, et al., supra note 3.Google Scholar
Knoppers, B. M. et al., “Framing Genomics, Public Health Research and Policy: Points to Consider”, Public Health Genomics 13, no. 4 (2010): 224–234.CrossRefGoogle ScholarPubMed
Stewart, A. et al., Genetics, Health Care and Public Policy: An Introduction to Public Health Genetics (Cambridge: Cambridge University Press, 2007).Google Scholar
Organization for Economic and Cultural Development, Citizens as Partners Information, Consultation and Public Participation in Policy Making (2001)World Health Organization, Ninth Futures Forum on Health Systems Governance and Public Participation, ISBN 92 890 2189 6 (October 11, 2005) UNESCO, Universal Declaration on Bioethics and Human Rights (October 19, 2005).Google Scholar
See Avard, et al., supra note 3.Google Scholar
See Andorno, , supra note 2.Google Scholar
UNESCO, Universal Declaration on the Human Genome and Human Rights, Article 5c (December 11, 1997).Google Scholar
UNESCO, Universal Declaration on Human Genetic Data, Article 10 (October 16, 2003).Google Scholar
See, for example, the adult carrier screening program run by the Health and Social Services Agency of Saguenay-Lac Saint Jean in Quebec, Canada, initiated in 2010. This program screens those at risk for Autosomal recessive spastic ataxia of Charlevoix-Saguenay; Leigh Syndrome, French-Canadian type; Tyrosinemia Type I; and Agenesis of the Corpus Callosum with Peripheral Neuropathy in order to provide reproductive decision-making information. See <http://www.santesaglac.gouv.qc.ca/index.html> for more information.+for+more+information.>Google Scholar
See Andorno, , supra note 2.Google Scholar
See Brand, , supra note 11.Google Scholar
See Cleeren, , supra note 12.Google Scholar
See Massée, , supra note 4.Google Scholar
Joly, Y. Feze, I. N., and Simard, J., “Genetic Discrimination and Life Insurance: A Systematic Review of the Evidence”, BMC Medicine 11, no. 25 (2013): Available at <http://www.biomedcentral.com/1741-7015/11/25> (last visited January 14, 2014).CrossRefGoogle Scholar
See Boyce, Borry, , supra note 6.Google Scholar
See Brand, et al., supra note 11.Google Scholar
See Cleeren, et al., supra note 12.Google Scholar
Collins, F. S., “Shattuck Lecture – Medical and Societal Consequences of the Human Genome Project”, New England Journal of Medicine 341, no. 1 (1999): 28–37.CrossRefGoogle ScholarPubMed
McClure, J. B., “Are Biomarkers a Useful Aid in Smoking Cessation? A Review and Analysis of the Literature”, Behavioral Medicine 27, no. 1 (2001): 37–47.CrossRefGoogle ScholarPubMed
See Cleeren, et al., supra note 12.Google Scholar
See Carlsten, Burke, , supra note 5.Google Scholar
Berrettini, W. Lerman, C. E., “Pharmacotherapy and Pharmacogenetics of Nicotine Dependence”, American Journal of Psychiatry 162, no. 8 (2005): 1441–1451.CrossRefGoogle ScholarPubMed
Acharya, K. Ackerman, P. D., and Ross, L. F., “Pediatricians’ Attitudes towards Expanding Newborn Screening”, Pediatrics 116, no. 4 (2005): e476–e484.CrossRefGoogle Scholar
Tarini, B. A. Goldenberg, A. J., “Ethical Issues with Newborn Screening in the Genomics Era”, Annual Review of Genomics and Human Genetics 13 (2012): 381–393 Wade, C. H. Tarini, B. A., and Wilfond, B. S., Growing up in the Genomic Era: Implications of Whole-Genome Sequencing for Children, Families, and Pediatric Practice, Annual Review of Genomics and Human Genetics 14 (2013): 535–555 Miller, F. A. Hayeems, R. Z., and Bombard, Y. et al., Clinical Obligations and Public Health Programmes: Healthcare Provider Reasoning about Managing the Incidental Results of Newborn Screening, Journal of Medical Ethics 35, no. 10 (2009): 626–634.CrossRefGoogle ScholarPubMed
Committee on Bioethics, Committee on Genetics, The American College of Medical Genetics, Genomics, Social Ethical Legal Issues Committee, Ethical Issues in Genetic Testing and Screening of Children, Pediatrics 131, no. 3 (2013): 620–622 Pollitt, R. J. “Introducing New Screens: Why Are We All Doing Different Things?”, Journal of Inherited Metabolic Disease 30, no. 4 (2007): 423–429 Ross, L. F. et al., Technical Report: Ethical and Policy Issues in Genetic Testing and Screening Children, Genetics in Medicine 15, no. 3 (2013): 234–245.CrossRefGoogle ScholarPubMed
Knoppers, B. M., “Paediatric Research and the Communication of Not-So-Incidental Findings”, Paediatrics & Child Health 17, no. 4 (2012): 190–192; Knoppers, B. M. Rioux, A., and Zawati, M., Pediatric Research ‘Personalized’? International Perspectives on the Return of Results, Future in Medicine 10, no. 1 (2013): 89–95.CrossRefGoogle ScholarPubMed
Bredenoord, A. L. de Vries, M. C., and van Delden, J. J. M., “Next-Generation Sequencing: Does the Next Generation Still Have a Right to an Open Future”, Nature Reviews Genetics 14, no. 5 (2013): 306.CrossRefGoogle ScholarPubMed
See Bayer, Fairchild, , supra note 1; Howard, H. C. et al., The Ethical Introduction of Genome Based Information and Technologies into Public Health, Public Health Genomics (2013).Google Scholar
See Bredenoord, , supra note 50.Google Scholar
Health Council of the Netherlands, The ‘Thousand-Dollar Genome’: An Ethical Exploration, Monitoring Report Ethics and Health, February 2010.Google Scholar
See Avard, et al., supra note 3.Google Scholar